Frontiers in Medicine (Sep 2022)

The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases

  • Carla Gaggiano,
  • Antonio Vitale,
  • Abdurrahman Tufan,
  • Gaafar Ragab,
  • Gaafar Ragab,
  • Emma Aragona,
  • Ewa Wiesik-Szewczyk,
  • Djouher Ait-Idir,
  • Giovanni Conti,
  • Ludovica Iezzi,
  • Maria Cristina Maggio,
  • Marco Cattalini,
  • Francesco La Torre,
  • Giuseppe Lopalco,
  • Elena Verrecchia,
  • Elena Verrecchia,
  • Amato de Paulis,
  • Amato de Paulis,
  • Ali Sahin,
  • Antonella Insalaco,
  • Petros P. Sfikakis,
  • Achille Marino,
  • Micol Frassi,
  • Benson Ogunjimi,
  • Benson Ogunjimi,
  • Benson Ogunjimi,
  • Benson Ogunjimi,
  • Daniela Opris-Belinski,
  • Paola Parronchi,
  • Giacomo Emmi,
  • Farhad Shahram,
  • Francesco Ciccia,
  • Matteo Piga,
  • José Hernández-Rodríguez,
  • Rosa Maria R. Pereira,
  • Maria Alessio,
  • Roberta Naddei,
  • Alma Nunzia Olivieri,
  • Emanuela Del Giudice,
  • Paolo Sfriso,
  • Piero Ruscitti,
  • Francesca Li Gobbi,
  • Hamit Kucuk,
  • Jurgen Sota,
  • Mohamed A. Hussein,
  • Giuseppe Malizia,
  • Karina Jahnz-Różyk,
  • Rawda Sari-Hamidou,
  • Mery Romeo,
  • Francesca Ricci,
  • Fabio Cardinale,
  • Florenzo Iannone,
  • Francesca Della Casa,
  • Marco Francesco Natale,
  • Katerina Laskari,
  • Teresa Giani,
  • Franco Franceschini,
  • Vito Sabato,
  • Derya Yildirim,
  • Valeria Caggiano,
  • Mohamed Tharwat Hegazy,
  • Mohamed Tharwat Hegazy,
  • Rosalba Di Marzo,
  • Aleksandra Kucharczyk,
  • Ghalia Khellaf,
  • Maria Tarsia,
  • Ibrahim A. Almaghlouth,
  • Ibrahim A. Almaghlouth,
  • Ahmed Hatem Laymouna,
  • Violetta Mastrorilli,
  • Laura Dotta,
  • Luca Benacquista,
  • Salvatore Grosso,
  • Francesca Crisafulli,
  • Veronica Parretti,
  • Heitor F. Giordano,
  • Ayman Abdel-Monem Ahmed Mahmoud,
  • Rossana Nuzzolese,
  • Marta De Musso,
  • Cecilia Beatrice Chighizola,
  • Cecilia Beatrice Chighizola,
  • Stefano Gentileschi,
  • Mirella Morrone,
  • Ilenia Di Cola,
  • Veronica Spedicato,
  • Henrique A. Mayrink Giardini,
  • Ibrahim Vasi,
  • Alessandra Renieri,
  • Alessandra Renieri,
  • Alessandra Renieri,
  • Alessandra Fabbiani,
  • Alessandra Fabbiani,
  • Alessandra Fabbiani,
  • Maria Antonietta Mencarelli,
  • Bruno Frediani,
  • Alberto Balistreri,
  • Gian Marco Tosi,
  • Claudia Fabiani,
  • Merav Lidar,
  • Merav Lidar,
  • Merav Lidar,
  • Donato Rigante,
  • Donato Rigante,
  • Luca Cantarini

DOI
https://doi.org/10.3389/fmed.2022.980679
Journal volume & issue
Vol. 9

Abstract

Read online

ObjectiveThe present manuscript aims to describe an international, electronic-based, user-friendly and interoperable patient registry for monogenic autoinflammatory diseases (mAIDs), developed in the contest of the Autoinflammatory Diseases Alliance (AIDA) Network.MethodsThis is an electronic platform, based on the Research Electronic Data Capture (REDCap) tool, used for real-world data collection of demographics, clinical, laboratory, instrumental and socioeconomic data of mAIDs patients. The instrument has flexibility, may change over time based on new scientific acquisitions, and communicate potentially with other similar registries; security, data quality and data governance are corner stones of the platform.ResultsAIDA project will share knowledge and expertise on mAIDs. Since its start, 118 centers from 24 countries and 4 continents have joined the AIDA project. Fifty-nine centers have already obtained the approval from their local Ethics Committees. Currently, the platform counts 337 users (122 Principal Investigators, 210 Site Investigators, 2 Lead Investigators, and 3 data managers). The Registry collects baseline and follow-up data using 3,748 fields organized into 21 instruments, which include demographics, patient history, symptoms, trigger/risk factors, therapies, and healthcare information for mAIDs patients.ConclusionsThe AIDA mAIDs Registry, acts both as a research tool for future collaborative real-life studies on mAIDs and as a service to connect all the figures called to participate. On this basis, the registry is expected to play a pivotal role in generating new scientific evidence on this group of rare diseases, substantially improving the management of patients, and optimizing the impact on the healthcare system. NCT 05200715 available at https://clinicaltrials.gov.

Keywords